← All decks

Cardiology

Percutaneous Therapies for Mitral Valve Disease Valvuloplasty for Mitral Stenosis and Percut

Built from Cardiovascular Catheterization and Intervention: A Textbook of Coronary, Peripheral, and Structural Heart Disease

What’s inside

10 sections · 187 slides

  1. 01

    Burden of mitral valve disease and mitral anatomy

    • Prevalence of mitral regurgitation
    • Changing epidemiology of mitral stenosis
    • Why transcatheter mitral therapy developed
    • Components of the mitral valve complex
    • Mitral valve anatomy on echocardiography and computed tomography
    • Structure of the mitral annulus
    • Carpentier scallop nomenclature
    • Types of chordae tendineae
    • Papillary muscle supply to leaflet segments

    9 slides

  2. 02

    Mitral stenosis: mechanism and assessment

    • Etiology of mitral stenosis
    • Mechanism of rheumatic valve damage
    • Rheumatic mitral stenosis on transesophageal echocardiography
    • Rheumatic mitral stenosis by region
    • Degenerative mitral stenosis
    • Risk associations of mitral annular calcification
    • Uncommon causes of mitral stenosis
    • Clinical manifestations of mitral stenosis
    • Auscultatory findings in mitral stenosis
    • Mitral valve area and severity thresholds
    • Limitations of the transmitral gradient
    • Scoring systems for commissurotomy eligibility
    • Reading the Wilkins score
    • Wilkins score for assessment of mitral valve anatomy before percutaneous mitral balloon commissurotomy
    • Stress testing when symptoms are discordant
    • Cardiac catheterization in mitral stenosis
    • Role of transesophageal echocardiography before commissurotomy
    • Transesophageal echocardiography in commissurotomy planning
    • Computed tomography in degenerative mitral stenosis

    19 slides

  3. 03

    Percutaneous mitral commissurotomy

    • Medical therapy in rheumatic mitral stenosis
    • Class I indication for percutaneous mitral commissurotomy
    • Commissurotomy in asymptomatic severe rheumatic stenosis
    • Guideline divergence above 1.5 cm²
    • Contraindications to commissurotomy
    • Concomitant disease precluding commissurotomy
    • Unfavourable anatomy for commissurotomy
    • Development of balloon commissurotomy
    • The double-balloon technique
    • The Inoue balloon
    • Inoue balloon components
    • The Inoue balloon set
    • Inflation behaviour of the Inoue balloon
    • The Accura balloon
    • Selecting balloon size
    • Intra-procedural measurement of the stenotic mitral valve area
    • Access and sedation for commissurotomy
    • Transseptal puncture for commissurotomy
    • Crossing the mitral valve with the Inoue balloon
    • Balloon dilatation and stepwise sizing
    • Endpoint of stepwise dilatation
    • Balloon commissurotomy under fluoroscopy
    • Complications of percutaneous mitral commissurotomy
    • Reducing procedural risk
    • Declining utilisation and operator proficiency
    • Pulmonary vascular disease and timing of intervention
    • Percutaneous commissurotomy: summary position

    27 slides

  4. 04

    Degenerative mitral stenosis

    • Indications for intervention in degenerative stenosis
    • Difficulty of valve replacement in annular calcification
    • Early transcatheter replacement using aortic valves
    • Transcatheter valve therapy registry outcomes
    • Outcomes of valve-in-mitral annular calcification
    • MITRAL trial results in the calcification arm
    • Left ventricular outflow tract obstruction in calcific disease
    • Reported incidence of outflow tract obstruction
    • Preventive strategies for outflow tract obstruction
    • Current status of replacement in degenerative stenosis
    • Dedicated devices in mitral annular calcification
    • Tendyne and the SUMMIT trial calcification cohort
    • Intrepid and Cephea experience
    • Ongoing trials with dedicated calcification arms

    14 slides

  5. 05

    Mitral regurgitation: mechanism and assessment

    • Acute mitral regurgitation
    • Carpentier classification of mitral regurgitation
    • Mechanisms of mitral regurgitation by leaflet motion
    • Type I mitral regurgitation
    • Type II mitral regurgitation
    • Fibroelastic deficiency and myxomatous disease
    • Type III mitral regurgitation
    • Primary and secondary disease within the classification
    • Haemodynamic consequences of mitral regurgitation
    • Symptoms and examination in mitral regurgitation
    • Echocardiography in mitral regurgitation
    • Three-dimensional imaging of the mitral valve
    • Cardiac magnetic resonance and computed tomography
    • Quantitative thresholds for severe regurgitation
    • Supportive Doppler signs of severe regurgitation

    15 slides

  6. 06

    Treatment indications in mitral regurgitation

    • Medical therapy for mitral regurgitation
    • Surgery in primary mitral regurgitation
    • Edge-to-edge repair in primary mitral regurgitation
    • Secondary mitral regurgitation and the Heart Team
    • Surgery in secondary mitral regurgitation
    • COAPT criteria for edge-to-edge repair
    • Position of transcatheter replacement in guidelines

    7 slides

  7. 07

    The transcatheter menu for mitral regurgitation

    • Categories of transcatheter mitral therapy
    • Coaptation devices for edge-to-edge repair
    • Transcatheter annuloplasty devices
    • Chordal replacement and ventricular remodelling devices

    4 slides

  8. 08

    Transcatheter edge-to-edge repair

    • Origin of edge-to-edge repair
    • EVEREST II trial
    • Early approvals and registry evidence
    • MITRA-FR trial
    • COAPT trial
    • Why MITRA-FR and COAPT differed
    • PASCAL system and the CLASP IID trial
    • Edge-to-edge repair in acute mitral regurgitation after infarction
    • Edge-to-edge repair in severe left ventricular dysfunction
    • Edge-to-edge repair in hypertrophic obstructive cardiomyopathy
    • MitraClip system components
    • Edge-to-edge repair clip system and clip sizes
    • MitraClip clip sizes
    • PASCAL system components
    • PASCAL delivery system and implants
    • PASCAL implant design
    • Access and transseptal puncture for edge-to-edge repair
    • Optimal transseptal puncture during edge-to-edge repair
    • Advancing the device into the left atrium
    • Imaging guidance during edge-to-edge repair
    • Aligning the device with the coaptation line
    • Leaflet grasping during edge-to-edge repair
    • Grasping and assessing the result
    • Release and additional devices
    • Unsuitability for repair: risk of iatrogenic stenosis
    • Unsuitability for repair: inadequate regurgitation reduction
    • Unsuitability for repair: technical and imaging barriers
    • Unsuitability for repair: futility
    • Patients outside the COAPT criteria

    29 slides

  9. 09

    Transcatheter mitral valve replacement

    • Rationale for transcatheter replacement
    • CHOICE-MI registry outcomes
    • Determinants of survival after replacement
    • Design constraints of replacement devices
    • Valve frame and prosthetic leaflets
    • Why radial force alone cannot anchor a mitral prosthesis
    • Anchoring mechanisms of replacement devices
    • Sealing mechanisms
    • Reading the device table
    • Transcatheter mitral valve replacement devices: available valve sizes
    • Transcatheter mitral valve replacement devices: anchoring mechanism
    • Transcatheter mitral valve replacement devices: access and reported evidence
    • Transcatheter mitral valve replacement devices: stated advantages
    • Transcatheter mitral valve replacement devices: stated advantages (continued)
    • Transcatheter mitral valve replacement devices: stated advantages (continued)
    • Transcatheter mitral valve replacement devices: potential disadvantages
    • Device shapes that follow from the anchoring problem
    • Atrial cage anchoring
    • Wide atrial flange with a short ventricular skirt
    • Inner valve stent within an outer sealing frame
    • Multiple anchors engaging annulus and subvalvular tissue
    • Crown-shaped atrial frame over a covered ventricular body
    • Broad atrial flange with a tri-leaflet bioprosthesis
    • D-shaped outer frame with a sewn sealing cuff
    • Valve seated within a separate docking ring
    • Apical tether with an epicardial pad
    • Left ventricular outflow tract obstruction after replacement
    • The neo-LVOT concept
    • Limits of neo-LVOT prediction
    • LAMPOON leaflet laceration
    • SESAME septal scoring
    • Septal reduction to enlarge the neo-LVOT
    • Screen failure in transcatheter mitral replacement
    • Antithrombotic therapy after replacement

    34 slides

  10. 10

    Choosing between the options

    • Repair compared with replacement
    • Patients who remain untreatable
    • Key points: mitral stenosis
    • Key points: mitral regurgitation
    • References
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • Cardiovascular Catheterization and Intervention: A Textbook of Coronary, Peripheral, and Structural Heart Disease
    • Join our WhatsApp groups

    19 slides